Live at #NSGC22: Precision medicine – now and next

preview_player
Показать описание
Dale Muzzey, Ph.D., chief scientific officer, Myriad Genetics and Katie Ziegler, regional medical specialist, Myriad Genetics.
  1. Myriad Genetics
Рекомендации по теме
Live at #NSGC22: 0:18:37

Live at #NSGC22: Precision medicine – now and next

Live at #NSGC22: 0:14:24

Live at #NSGC22: Empowering women to take control of their breast health

Excited to be 0:03:01

Excited to be back in person at #NSGC22

Live at #NSGC22: 0:11:59

Live at #NSGC22: Advancing health equity in prenatal care

Live at #NSGC22: 0:06:01

Live at #NSGC22: Fireside chat with Myriad Genetics president and CEO, Paul J. Diaz

Precise Oncology Solutions: 0:01:19

Precise Oncology Solutions: Nicole Lambert

Precise Registry: Dario 0:01:22

Precise Registry: Dario Roque, M.D.

Myriad Genetics at 0:02:31

Myriad Genetics at SGO 2022

Myriad Genetics at 0:03:01

Myriad Genetics at 2022 San Antonio Breast Cancer Symposium

Addition of riskScore 0:01:16

Addition of riskScore to Myriad's myRisk Hereditary Cancer Test

Dr. Robert Coleman 0:02:09

Dr. Robert Coleman shares his perspective on what is next in cancer care

Myriad Genetics 2021 0:22:22

Myriad Genetics 2021 Investor Day Highlights

Myriad Genetics: 2021 0:03:37

Myriad Genetics: 2021 year in review

Prolaris® provides clarity 0:04:11

Prolaris® provides clarity for prostate cancer treatment decisions. A patient story.

Myriad Genetics: A 0:05:04

Myriad Genetics: A look back at 2022

Inputs to Action 0:35:21

Inputs to Action with Laura Crandon

WHS - When 0:55:21

WHS - When We Tri(al): Overcoming Breast Cancer Disparities

visit shbcf.ru